Report Detail

Pharma & Healthcare Global Parkinson's Disease Treatment Market Professional Survey Report 2018

  • RnM2006865
  • |
  • 03 April, 2019
  • |
  • Global
  • |
  • 129 Pages
  • |
  • XYZResearch
  • |
  • Pharma & Healthcare

This report focuses on top manufacturers in global market, with Sales, price, revenue and market share for each manufacturer, covering
Teva (Israel)
Novartis AG (Switzerland)
GSK (UK)
AbbVie (US)
Merck (US)
Boehringer Ingelheim (Germany)
Impax Laboratories (US)
Lundbeck (Denmark)
UCB (Belgium)
Valeant Pharmaceuticals (Canada)
Acadia (US)
Sun Pharma (India)
Wockhardt (India)
Dr. Reddy's (India)
Intas (India)
...

On the basis of product, this report displays the Sales, revenue, price, market share and growth rate of each type, primarily split into
Levodopa/carbidopa
Dopamine Receptor Agonists
MAO-Inhibitors
COMT-inhibitors
Anticholinergics
Other Drugs

By Application, the market can be split into
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America

By Regions, this report covers (we can add the regions/countries as you want)

If you have any special requirements, please let us know and we will offer you the report as you want.


Table of Contents

    Global Parkinson's Disease Treatment Market Professional Survey Report 2017

      1 Report Overview

      • 1.1 Definition and Specification
      • 1.2 Report Overview
        • 1.2.1 Manufacturers Overview
        • 1.2.2 Regions Overview
        • 1.2.3 Type Overview
        • 1.2.4 Application Overview
      • 1.3 Industrial Chain
        • 1.3.1 Parkinson's Disease Treatment Overall Industrial Chain
        • 1.3.2 Upstream
        • 1.3.3 Downstream
      • 1.4 Industry Situation
        • 1.4.1 Industrial Policy
        • 1.4.2 Product Preference
        • 1.4.3 Economic/Political Environment
      • 1.5 SWOT Analysis

      2 Market Analysis by Types

      • 2.1 Overall Market Performance(Volume)
        • 2.1.1 Levodopa/carbidopa Market Performance (Volume)
        • 2.1.2 Dopamine Receptor Agonists Market Performance (Volume)
        • 2.1.3 MAO-Inhibitors Market Performance (Volume)
        • 2.1.4 COMT-inhibitors Market Performance (Volume)
        • 2.1.5 Anticholinergics Market Performance (Volume)
      • 2.2 Overall Market Performance(Value)
        • 2.1.1 Levodopa/carbidopa Market Performance (Value)
        • 2.1.2 Dopamine Receptor Agonists Market Performance (Value)
        • 2.1.3 MAO-Inhibitors Market Performance (Value)
        • 2.1.4 COMT-inhibitors Market Performance (Value)
        • 2.1.5 Anticholinergics Market Performance (Value)

      3 Product Application Market

      • 3.1 Overall Market Performance (Volume)
        • 3.1.1 Hospital Pharmacies Market Performance (Volume)
        • 3.1.2 Retailer Pharmacies Market Performance (Volume)
        • 3.1.3 Online Pharmacies Market Performance (Volume)

      4 Manufacturers Profiles/Analysis

      • 4.1 Teva (Israel)
        • 4.1.1 Teva (Israel) Profiles
        • 4.1.2 Teva (Israel) Product Information
        • 4.1.3 Teva (Israel) Parkinson's Disease Treatment Business Performance
        • 4.1.4 Teva (Israel) Parkinson's Disease Treatment Business Development and Market Status
      • 4.2 Novartis AG (Switzerland)
        • 4.2.1 Novartis AG (Switzerland) Profiles
        • 4.2.2 Novartis AG (Switzerland) Product Information
        • 4.2.3 Novartis AG (Switzerland) Parkinson's Disease Treatment Business Performance
        • 4.2.4 Novartis AG (Switzerland) Parkinson's Disease Treatment Business Development and Market Status
      • 4.3 GSK (UK)
        • 4.3.1 GSK (UK) Profiles
        • 4.3.2 GSK (UK) Product Information
        • 4.3.3 GSK (UK) Parkinson's Disease Treatment Business Performance
        • 4.3.4 GSK (UK) Parkinson's Disease Treatment Business Development and Market Status
      • 4.4 AbbVie (US)
        • 4.4.1 AbbVie (US) Profiles
        • 4.4.2 AbbVie (US) Product Information
        • 4.4.3 AbbVie (US) Parkinson's Disease Treatment Business Performance
        • 4.4.4 AbbVie (US) Parkinson's Disease Treatment Business Development and Market Status
      • 4.5 Merck (US)
        • 4.5.1 Merck (US) Profiles
        • 4.5.2 Merck (US) Product Information
        • 4.5.3 Merck (US) Parkinson's Disease Treatment Business Performance
        • 4.5.4 Merck (US) Parkinson's Disease Treatment Business Development and Market Status
      • 4.6 Boehringer Ingelheim (Germany)
        • 4.6.1 Boehringer Ingelheim (Germany) Profiles
        • 4.6.2 Boehringer Ingelheim (Germany) Product Information
        • 4.6.3 Boehringer Ingelheim (Germany) Parkinson's Disease Treatment Business Performance
        • 4.6.4 Boehringer Ingelheim (Germany) Parkinson's Disease Treatment Business Development and Market Status
      • 4.7 Impax Laboratories (US)
        • 4.7.1 Impax Laboratories (US) Profiles
        • 4.7.2 Impax Laboratories (US) Product Information
        • 4.7.3 Impax Laboratories (US) Parkinson's Disease Treatment Business Performance
        • 4.7.4 Impax Laboratories (US) Parkinson's Disease Treatment Business Development and Market Status
      • 4.8 Lundbeck (Denmark)
        • 4.8.1 Lundbeck (Denmark) Profiles
        • 4.8.2 Lundbeck (Denmark) Product Information
        • 4.8.3 Lundbeck (Denmark) Parkinson's Disease Treatment Business Performance
        • 4.8.4 Lundbeck (Denmark) Parkinson's Disease Treatment Business Development and Market Status
      • 4.9 UCB (Belgium)
        • 4.9.1 UCB (Belgium) Profiles
        • 4.9.2 UCB (Belgium) Product Information
        • 4.9.3 UCB (Belgium) Parkinson's Disease Treatment Business Performance
        • 4.9.4 UCB (Belgium) Parkinson's Disease Treatment Business Development and Market Status
      • 4.10 Valeant Pharmaceuticals (Canada)
        • 4.10.1 Valeant Pharmaceuticals (Canada) Profiles
        • 4.10.2 Valeant Pharmaceuticals (Canada) Product Information
        • 4.10.3 Valeant Pharmaceuticals (Canada) Parkinson's Disease Treatment Business Performance
        • 4.10.4 Valeant Pharmaceuticals (Canada) Parkinson's Disease Treatment Business Development and Market Status
      • 4.11 Acadia (US)
      • 4.12 Sun Pharma (India)
      • 4.13 GSK (UK)
      • 4.14 AbbVie (US)
      • 4.15 Merck (US)

      5 Market Performance for Manufacturers

      • 5.1 Global Parkinson's Disease Treatment Capacity (K Units) and Market Share by Manufacturers 2013-2018
      • 5.2 Global Parkinson's Disease Treatment Sales (K Units) and Market Share by Manufacturers 2013-2018
      • 5.3 Global Parkinson's Disease Treatment Revenue (M USD) and Market Share by Manufacturers 2013-2018
      • 5.4 Global Parkinson's Disease Treatment Price (USD/Unit) of Manufacturers 2013-2018
      • 5.5 Global Parkinson's Disease Treatment Gross Margin of Manufacturers 2013-2018
      • 5.6 Market Concentration

      6 Regions Market Performance for Manufacturers

      • 6.1 China Market Performance for Manufacturers
        • 6.1.1 China Parkinson's Disease Treatment Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.1.2 China Parkinson's Disease Treatment Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.1.3 China Parkinson's Disease Treatment Price (USD/Unit) of Manufacturers 2013-2018
        • 6.1.4 China Parkinson's Disease Treatment Gross Margin of Manufacturers 2013-2018
        • 6.1.5 Market Concentration
      • 6.2 USA Market Performance for Manufacturers
        • 6.2.1 USA Parkinson's Disease Treatment Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.2.2 USA Parkinson's Disease Treatment Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.2.3 USA Parkinson's Disease Treatment Price (USD/Unit) of Manufacturers 2013-2018
        • 6.2.4 USA Parkinson's Disease Treatment Gross Margin of Manufacturers 2013-2018
        • 6.2.5 Market Concentration
      • 6.3 Europe Market Performance for Manufacturers
        • 6.3.1 Europe Parkinson's Disease Treatment Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.3.2 Europe Parkinson's Disease Treatment Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.3.3 Europe Parkinson's Disease Treatment Price (USD/Unit) of Manufacturers 2013-2018
        • 6.3.4 Europe Parkinson's Disease Treatment Gross Margin of Manufacturers 2013-2018
        • 6.3.5 Market Concentration
      • 6.4 Japan Market Performance for Manufacturers
        • 6.4.1 Japan Parkinson's Disease Treatment Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.4.2 Japan Parkinson's Disease Treatment Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.4.3 Japan Parkinson's Disease Treatment Price (USD/Unit) of Manufacturers 2013-2018
        • 6.4.4 Japan Parkinson's Disease Treatment Gross Margin of Manufacturers 2013-2018
        • 6.4.5 Market Concentration
      • 6.5 Korea Market Performance for Manufacturers
        • 6.5.1 Korea Parkinson's Disease Treatment Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.5.2 Korea Parkinson's Disease Treatment Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.5.3 Korea Parkinson's Disease Treatment Price (USD/Unit) of Manufacturers 2013-2018
        • 6.5.4 Korea Parkinson's Disease Treatment Gross Margin of Manufacturers 2013-2018
        • 6.5.5 Market Concentration
      • 6.6 India Market Performance for Manufacturers
        • 6.6.1 India Parkinson's Disease Treatment Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.6.2 India Parkinson's Disease Treatment Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.6.3 India Parkinson's Disease Treatment Price (USD/Unit) of Manufacturers 2013-2018
        • 6.6.4 India Parkinson's Disease Treatment Gross Margin of Manufacturers 2013-2018
        • 6.6.5 Market Concentration
      • 6.7 Southeast Asia Market Performance for Manufacturers
        • 6.7.1 Southeast Asia Parkinson's Disease Treatment Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.7.2 Southeast Asia Parkinson's Disease Treatment Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.7.3 Southeast Asia Parkinson's Disease Treatment Price (USD/Unit) of Manufacturers 2013-2018
        • 6.7.4 Southeast Asia Parkinson's Disease Treatment Gross Margin of Manufacturers 2013-2018
        • 6.7.5 Market Concentration
      • 6.8 South America Market Performance for Manufacturers
        • 6.8.1 South America Parkinson's Disease Treatment Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.8.2 South America Parkinson's Disease Treatment Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.8.3 South America Parkinson's Disease Treatment Price (USD/Unit) of Manufacturers 2013-2018
        • 6.8.4 South America Parkinson's Disease Treatment Gross Margin of Manufacturers 2013-2018
        • 6.8.5 Market Concentration

      7 Global Parkinson's Disease Treatment Market Performance (Sales Point)

      • 7.1 Global Parkinson's Disease Treatment Capacity (K Units) and Market Share by Regions 2013-2018
      • 7.2 Global Parkinson's Disease Treatment Sales (K Units) and Market Share by Regions 2013-2018
      • 7.3 Global Parkinson's Disease Treatment Revenue (M USD) and Market Share by Regions 2013-2018
      • 7.4 Global Parkinson's Disease Treatment Price (USD/Unit) by Regions 2013-2018
      • 7.5 Global Parkinson's Disease Treatment Gross Margin by Regions 2013-2018

      8 Development Trend for Regions (Sales Point)

      • 8.1 Global Parkinson's Disease Treatment Capacity and Growth, Sales Value and Growth Rate2013-2018
      • 8.2 China Parkinson's Disease Treatment Capacity and Growth, Sales Value and Growth Rate2013-2018
      • 8.3 USA Parkinson's Disease Treatment Capacity and Growth, Sales Value and Growth Rate2013-2018
      • 8.4 Europe Parkinson's Disease Treatment Capacity and Growth, Sales Value and Growth Rate2013-2018
      • 8.5 Japan Parkinson's Disease Treatment Capacity and Growth, Sales Value and Growth Rate2013-2018
      • 8.6 Korea Parkinson's Disease Treatment Capacity and Growth, Sales Value and Growth Rate2013-2018
      • 8.7 India Parkinson's Disease Treatment Capacity and Growth, Sales Value and Growth Rate2013-2018
      • 8.8 Southeast Asia Parkinson's Disease Treatment Capacity and Growth, Sales Value and Growth Rate2013-2018
      • 8.9 Southeast Asia Parkinson's Disease Treatment Capacity and Growth, Sales Value and Growth Rate2013-2018

      9 Development Trend for Regions (Sales Point)

      • 9.1 Global Parkinson's Disease Treatment Sales and Growth, Sales Value and Growth Rate2013-2018
      • 9.2 China Parkinson's Disease Treatment Sales and Growth, Sales Value and Growth Rate2013-2018
      • 9.3 USA Parkinson's Disease Treatment Sales and Growth, Sales Value and Growth Rate2013-2018
      • 9.4 Europe Parkinson's Disease Treatment Sales and Growth, Sales Value and Growth Rate2013-2018
      • 9.5 Japan Parkinson's Disease Treatment Sales and Growth, Sales Value and Growth Rate2013-2018
      • 9.6 Korea Parkinson's Disease Treatment Sales and Growth, Sales Value and Growth Rate2013-2018
      • 9.7 India Parkinson's Disease Treatment Sales and Growth, Sales Value and Growth Rate2013-2018
      • 9.8 Southeast Asia Parkinson's Disease Treatment Sales and Growth, Sales Value and Growth Rate2013-2018
      • 9.9 South America Parkinson's Disease Treatment Sales and Growth, Sales Value and Growth Rate2013-2018

      10 Upstream Source, Technology and Cost

      • 10.1 Upstream Source
      • 10.2 Technology
      • 10.3 Cost

      11 Channel Analysis

      • 11.1 Market Channel
      • 11.2 Distributors

      12 Consumer Analysis

      • 12.1 Hospital Pharmacies Industry
      • 12.2 Retailer Pharmacies Industry
      • 12.3 Online Pharmacies Industry

      13 Market Forecast 2019-2024

      • 13.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
        • 13.1.1 Global Parkinson's Disease Treatment Capacity (K Units) and Share by Regions 2019-2024
        • 13.1.2 Global Parkinson's Disease Treatment Capacity (K Units), Sales (K Units) and Growth Rate 2019-2024
        • 13.1.3 China Parkinson's Disease Treatment Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 13.1.4 USA Parkinson's Disease Treatment Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 13.1.5 Europe Parkinson's Disease Treatment Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 13.1.6 Japan Parkinson's Disease Treatment Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 13.1.7 Korea Parkinson's Disease Treatment Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 13.1.8 India Parkinson's Disease Treatment Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 13.1.9 Southeast Asia Parkinson's Disease Treatment Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 13.1.10 South America Parkinson's Disease Treatment Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
        • 13.3.1 Overall Market Performance
        • 13.3.2 Levodopa/carbidopa Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 13.3.3 Dopamine Receptor Agonists Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 13.3.4 MAO-Inhibitors Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 13.3.5 COMT-inhibitors Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.4 Sales by Application 2019-2024
        • 13.4.1 Overall Market Performance
        • 13.4.2 Hospital Pharmacies Sales and and Growth Rate 2019-2024
        • 13.4.3 Retailer Pharmacies Sales and and Growth Rate 2019-2024
        • 13.4.4 Online Pharmacies Sales and and Growth Rate 2019-2024
      • 13.5 Price (USD/Unit) and Gross Profit
        • 13.5.1 Global Parkinson's Disease Treatment Price (USD/Unit) Trend 2019-2024
        • 13.5.2 Global Parkinson's Disease Treatment Gross Profit Trend 2019-2024

      14 Conclusion

      Summary:
      Get latest Market Research Reports on Parkinson's Disease Treatment . Industry analysis & Market Report on Parkinson's Disease Treatment is a syndicated market report, published as Global Parkinson's Disease Treatment Market Professional Survey Report 2018. It is complete Research Study and Industry Analysis of Parkinson's Disease Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $2,800.00
      $5,500.00
      2,217.60
      4,356.00
      2,587.20
      5,082.00
      423,612.00
      832,095.00
      233,436.00
      458,535.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report